Reblozyl 75 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26F9DY8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $39,791
Award facts
- Contract value 100% obligated
- $39,791.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $39,791.02 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Reblozyl 75 mg vials. This is a non-set-aside contract with an ultimate completion date of December 23, 2025, and was issued on December 2, 2025. Performance will occur at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Reblozyl is a specialized pharmaceutical product used primarily for treating certain blood disorders, reflecting the company's role as a critical supplier of both brand-name and generic medications to federal medical procurement systems.
This delivery order represents a task order executed under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion pharmaceutical supply vehicle valued through December 2026. The IDC enables the contractor to supply a wide range of pharmaceutical products and medical commodities to support military healthcare programs globally, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. AmerisourceBergen's consistent performance across competitively awarded federal contracts and its designation as a prime vendor in the DLA Medical Supply Chain underscore its significance as a key pharmaceutical distributor for the Department of Defense.
Quick answers
Who was awarded contract SPE2DR26F9DY8?
SPE2DR26F9DY8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DR26F9DY8 worth?
The government has obligated $39,791 on SPE2DR26F9DY8.
Is contract SPE2DR26F9DY8 an order under another contract?
Yes. SPE2DR26F9DY8 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9DY8 competed?
The extent of competition for SPE2DR26F9DY8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award